Drug
Combination OF Pimecrolimus And Fluticasone
Combination OF Pimecrolimus And Fluticasone: highest development phase Post-Market, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Combination of pimecrolimus and fluticasone NCT00119158 | Post-Market | Atopic Dermatitis |
Latest
No recent events.
Follow Combination OF Pimecrolimus And Fluticasone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.